Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00258_DB00978_nanopub.RAj8KWJChBWdGCud7fHne4VYk6QOF-20fqIdhkG96RVQY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00258_DB00978 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00258_DB00978 label "DDI between Calcium Acetate and Lomefloxacin - Calcium salts such as calcium acetate may decrease the absorption of quinolone antibiotics such as lomefloxacin. Of concern only with oral administration of both agents. Interactions can be minimized by administering oral quinolone at least 2 hours before, or 6 hours after, the dose of an oral calcium supplement. Monitor for decreased therapeutic effects of oral quinolones if administered with oral calcium supplements. [drugbank_resource:DB00258_DB00978]" assertion.
- drugbank_resource:DB00258_DB00978 identifier "drugbank_resource:DB00258_DB00978" assertion.
- drugbank_resource:DB00258_DB00978 title "DDI between Calcium Acetate and Lomefloxacin - Calcium salts such as calcium acetate may decrease the absorption of quinolone antibiotics such as lomefloxacin. Of concern only with oral administration of both agents. Interactions can be minimized by administering oral quinolone at least 2 hours before, or 6 hours after, the dose of an oral calcium supplement. Monitor for decreased therapeutic effects of oral quinolones if administered with oral calcium supplements." assertion.
- drugbank:DB00258 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00258_DB00978 assertion.
- drugbank:DB00978 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00258_DB00978 assertion.